
Kutty
Selva Nandakumar, Ph.D., Dr.Med.Sci.
Assistant
Professor
Medical
Inflammation Research, MBB, Karolinska Institute
Scheeles
väg 2
B2 Plan 4, 171 77 Stockholm
Tel: 08-524 87715;
08-524 86337; Fax: 08-524
87750: e-mail: Nandakumar.Kutty-Selva@ki.se
Education
Lund University,
Medical Inflammation Research, Medical Faculty
– Lund, Sweden. (http://www.med.lu.se/)
Mentor: Prof. Rikard Holmdahl
Doctor of
Philosophy (Ph.D.), Immunogenetics – January 2006
Madurai Kamaraj
University, Department of Immunology, School of
Biological Sciences – Madurai, India. (http://www.mkuniversity.org) Mentor: Prof.
VR. Muthukkaruppan
Doctor of
Philosophy (Ph.D.), Immunology – January 1996
- Thesis: Studies on the importance of porin, an outer membrane
protein, in murine and human typhoid.
University of
Madras – Department of Biochemistry,
PostGraduate Institute of Basic Medical Sciences, Taramani Campus,
Chennai,
India. (http://www.unom.ac.in)
Master of
Science (M.Sc.), Biochemistry – April 1988
University of
Madras – Department of Chemistry, Sacred Heart
College, Tiruppattur, (http://www.shctpt.edu/)
Bachelor of
Science (B.Sc.), Chemistry – April 1986
Lab and Research Experience
- Medical Inflammation Research,
MBB, Karolinska Institute, Stockholm, Sweden. Assistant
professor. From July 2008- (http://www.inflam.mbb.ki.se/)
- Lund University Diabetes
Centre/Medical Inflammation Research (LUDC), Malmö, Sweden. Research
Assistant, Identification of genes controlling both inflammation
and metabolic syndrome using a heterogeneous stock. From April
2007-June 2008 (http://www.med.lu.se/ludc)
- Hansa Medical AB/Medical
Inflammation Research (LU), Lund, Sweden. Research
Scientist, Theoretical investigation
on the use of a bacterial enzyme for treatment in IgG mediated
pathologies.
February 2007 to March 2007. (http://www.hansamedical.com/)
- Resistentia pharmaceuticals
AB/Medical Inflammation Research (LU), Uppsala/Lund, Sweden. Research Scientist, Vaccination studies in arthritis.
February 2006 to January 2007. (http://www.resistentia.se/)
- Medical Inflammation Research,
Lund University (LU), Lund, Sweden. Postdoctoral Fellow,
Development and characterization of an animal model for arthritis.
June1998 to May 2001. (http://www.med.lu.se)
- Center for Cellular and
Molecular Biology (CCMB), Hyderabad, India. Postdoctoral
Fellow, Immune responses to a histiocytic tumor in rats. January
1996 to May 1998. (www.ccmb.res.in)
- All India Institute of Medical
Sciences (AIIMS), Project student, Studies on the role
of complement in autoimmune diseases. New Delhi, India. 1988- 1989,
Department of Biochemistry. (http://www.aiims.edu)
Commission of Trust
- Adhoc
referee for the journals:
Arthritis Research Therapy, European Journal of
Immunology, Scandinavian Journal of Rheumatology, Biomaterials, Disease
markers and cancer biomarkers, Cytokine, Nature Protocols and BMC
Musculoskeletal Disorders.
- Evaluation of a
project (2008) for ARC grant (UK)
Field of Expertise
Immunology -
Immunogenetics
– inflammation – Arthritis - Infectious diseases (Salmonellosis) -
Tumor immunology
- Hybridoma – Antibodies - Animal models of human diseases –
Testing vaccines in mice – in vivo
experiments
Teacher
Training
course
Basic course on Oral communication (2002), Lund University; Basic
Course in Education for University Teachers (2009), LIME, Karolinska
Institute; Postgraduate supervisor training course (2009), LIME,
Karolinska Institute; Advanced course on Communication and
learning (2009), LIME, Karolinska Institute.
Teaching
experience (Total hours: 51.30 h+ 40 h)
Teaching in animal models for
human diseases, immunology and genetics for biomedical students,
organic chemistry for undergraduate students and research supervision.
Research
training for short duration
(min period: 3 months during 2002-2009)
M.Sc. students: 3; Ph.D.
students: 3; M.D. students: 2; BMA student: 1
Faculty
Opponent
Ph.D. dissertation - Mohammed
Mullazehi (May 2009). “Anti-collagen type II autoantibodies in an acute
phenotype of early Rheumatoid arthritis”. Department of Oncology,
Radiology and Clinical Immunology, Uppsala University, Uppsala,
Sweden.
Project Grants (year 2007) - Total: 415.000 SEK
1. Title: "Genetic and Immunologic
characterization of antibody-mediated arthritis in mice" and "Identification of genes controlling both inflammation and
metabolic syndrome
using a heterogeneous stock"
Foundations:
Alfred Österlunds
Foundation, Stiftelsen Professor Nanna Svartz fond,
Reumatikerforbundet, Konung
Gustaf V:s 80-Årsfond and Lund University Diabetic centre (LUDC)
Project Grants (year 2008) –Total:
800.480 SEK
Title: Studies
on genes and pathogenesis of inflammatory diseases
Foundations: Tore Nilssons
fond, Alfred
Österlunds Foundation, Greta och
Johan Kocks Stiftelser, Stiftelsen Professor Nanna Svartz fond,
Reumatikerforbundet, Alex och Eva Wallströms
stiftelse
and Konung Gustaf V:s 80-Årsfond
Project
Grants (year 2009)
1.
Individual Project Grants (year 2009) – Total: 925.000
SEK (so far)
1. Title: Studies
on genes and pathogenesis of inflammatory diseases
Foundations:
Konung Gustaf V:s 80-Årsfond, Åke Wibergs stiftelse and
Professor Nanna Svartz fond, Reumatikerforbundet, Alex and Eva
Wallstroms fond, AnneGreta Holger Crafoord fond and KI fond (Fobi
2009).
2.
Swedish National Collaborative Project Grant (year 2009 - 2011)
Title: "Towards
immune specific
diagnosis and prevention of rheumatoid arthritis"
(Main applicant:
Rikard
Holmdahl; Co-applicants: Johan Backlund, Vivi Malmstrom, Kutty
Selva Nandakumar and Ronald Van
Vollenhoven)
VR Collaborative
Grant
6.000.000
SEK
3.
International Collaborative project Grant (years 2009 –
2011)
Title:
"Analysis of Host Response to
Modified Biocompatible
Stimuli-responsive Polymers and Autoantigens Using Murine Experimental
arthritis"
Main applicants: Kutty
Selva
Nandakumar (Sweden) and Ashok Kumar (India)
VR Link Grant
600.000 SEK
Patents/applications: 3
1. Björck
L,
Holmdahl R and Nandakumar
KS – "IdeS
for treatment of IgG antibody mediated diseases and conditions in the
areas of
autoimmunity, hematology and transplantation" (2005). Patent Number: WO2006131347: Publication
date:
2006-12-14.
2. Olsson A,
Collin M, Björck L, Shannon O, Holmdahl R and Nandakumar
KS
– "Therapeutic
application of Endo S" (2006).
3. Blom A,
Holmdahl R and Nandakumar
KS - "C4bp
polypeptides and arthritis" (2008).
Current Supervisor Responsibility
Dorota
Klaczkowska: Main Supervisor -
Ph.D. student in Lund University and Karolinska Institutet from
Poland HT 2009 - current
Ia Khamzade: Main Supervisor - Ph.D. student in
Karolinka Institutet from Gerogia HT 2009 – current
Ingrid Lindh: Co-Supervisor - Ph.D. student in
Karolinska Institutet from Sweden – HT 2008 – current
Publications
Kielland A, Blom T,
Nandakumar KS,
Holmdahl R, Blomhoff R and
Carlsen H (2009). In vivo imaging of reactive oxidative species during
inflammation using the luminescent probe L-012. Free Radic Biol Med
2009 June 16 [Epub ahead of print]
PubMed
Nandakumar KS (2009).
Pathogenic antibody recognition of cartilage.
Cell and Tissue Res Jun 9. [Epub ahead of print]
PubMed
Johansson ÅCM,
Nandakumar KS,
Persson AM, Olsson I, Hansson M
(2009). Targeting of human soluble TNF-a receptor into secretory
lysosomes of murine hematopoietic cells in vivo as a principle for
immunoregulation in inflammation and malignancy Exp Hematol May 29.
[Epub ahead of print]
PubMed
Uysal H, Bockermann R, Nandakumar KS, Sehnart B,
Bajtner E, Engström
Å,
Burkhardt H, Thunnissen M and Holmdahl R (2009). Structure and
pathogenicity of antibodies specific for citrullinated type II
collagen. J Exp Med 206: 449-62. PubMed
Hultqvist M, Nandakumar
KS, Björklund U and Holmdahl R (2009). The novel
small
molecule Rob 803 is effective in reducing severity of disease in the
mouse models of autoimmune disorders. Ann
Rheum Dis 68:130-5.
Epub 2008 Mar
17 PubMed
Blom AM , Nandakumar KS , Holmdahl R (2009). C4
binding protein (C4BP) inhibits development of experimental arthritis Ann Rheum Dis 68:136-42. Epub 2008 Feb 14. Co-first
authors. PubMed
Geng H, Carlsen S, Nandakumar
KS, Holmdahl R, Aspberg A, Oldberg Å and Mattsson
R
(2008). The role of cartilage matrix protein (COMP) in collagen II
induced arthritis Arthritis Res Ther 10:R134. PubMed
Nilsang S, Nehru
V, Plieva F, Nandakumar
KS,
Rakshit SK, Holmdahl R, Mattiasson B and Kumar A (2008).
Three-dimensional culture for monoclonal antibody production by
hybridoma cells immobilized in macroporous gel particles. Biotechnology
Progress. 24:1122-31.
Nandakumar KS and Holmdahl R (2008). Role
of anti-hinge antibodies in therapeutic cleavage of IgG: response to
Drs. Lutz and Fumia. Trends in Immunology. 29:355-6.
Epub 2008 Jul 2 PubMed
Rowley M, Nandakumar
KS and Holmdahl R (2008). The role of collagen antibodies in
mediating arthritis. Mod Rheumatology Jun 3. [Epub ahead of print].PubMed
Carlsen S, Nandakumar KS, Backlund J, Holmberg J, Hultqvist M,
Vestberg M, and Holmdahl R (2008). Cartilage oligomeric matrix protein
induces chronic arthritis in mice. Arthritis and Rheumatism. 2008
Jul;58(7):2000-11. PubMed
Nandakumar KS* and Holmdahl R (2008).
Threapeutic cleavage of IgG – new avenues for treating inflammation.
Trends Immunol 29:173-8.
Epub 2008 Mar 6. PubMed
Uysal H, Sehnert B, Nandakumar KS, Böiers U, Burkhardt H, Holmdahl R,
Thunnissen M (2008). The crystal structure of the pathogenic collagen
type II specific mouse monoclonal antibody CIIC1 Fab: Structure to
function analysis. Mol Immunol 45:2196-2204.
Epub 2008 Feb 1. PubMed
Nandakumar
KS*,
Bajtner E,
Hill L, Böhm B, Rowley MJ, Burkhardt H and Holmdahl R (2008).Arthritogenic antibodies
specific for a major type II collagen triple helical epitope bind and
destabilize cartilage independent of inflammation. Arthritis Rheum
58:184-196. * -
corresponding author. PubMed
Nandakumar
KS
and Holmdahl R
(2007). Collagen antibody induced arthritis. Methods Mol Med
136:215-23. PubMed
Nandakumar KS*, Collin M, Olsen A,
Nimmerjahn F, Blom A, Ravetch JV and Holmdahl R (2007). Endoglycosidase treatment abrogates IgG
arthritogenicity – importance of IgG glycosylation in arthritis. Eur J
Immunol 37:2973-82. * -
corresponding author.PubMed
Gelderman KA, Hultqvist
M,
Pizzolla A, Zhao M, Nandakumar KS, Mattsson R and
Holmdahl R (2007). Macrophages suppress T cell responses by producing
reactive oxygen species (ROS). J Clin Invest 117:3020-8. PubMed
Nandakumar KS*, Johansson BP, Björck L
and
holmdahl R (2007). Blocking arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum 56:3253-60. * -
corresponding author.PubMed
Nilsang S, Nandakumar KS, Galaev IY, Rakshit SK, Holmdahl R,
Mattiasson B and Kumar A (2007). Monoclonal antibody production using a
new supermacroporous cryogel perfusion reactor. Biotechnology Progress 23:932-939. PubMed
Jonsson, IM, Verdrengh M,
Brisslert M, Lindblad S, Bokarewa M, Islander U, Carlsten H, Ohlsson C,
Nandakumar KS, Holmdahl R, Tarkowski A (2007).
Ethanol prevents development of destructive arthritis. PNAS
104:258-263. PubMed
Madsen T, Ujvari B, Nandakumar KS, Hasselquist D and Holmdal R. (2007). Do
infectious prey select for high levels of natural antibodies in
tropical pythons? Evol Ecol 21:271–279. WOS
Nandakumar KS* and Holmdahl R (2006).
Antibody induced arthritis – disease mechanisms and genes involved at
the effector phase of arthritis. Arthritis Res Ther 8:223-233. Review. * -
corresponding author.PubMed
Lindqvist A-K B,
Johannesson M, Johansson ÅCM, Nandakumar
KS, Blom
A,
Holmdahl R (2006). Backcross and partial advanced intercross analysis
of NOD gene mediated effects on collagen induced arthritis reveals an
interactive effect by two major loci J Immunol 177:3952-3959. PubMed
Carlsen S, Nandakumar
KS and Holmdahl R (2006). Type IX collagen deficiency enhances
binding of cartilage specific antibodies and arthritis severity
Arthritis Res Ther 8:R102. PubMed
Sehnert B, Gierer P,
Ibrahim
S, Kuhl A, Voll R, Nandakumar KS, Holmdahl R, Hallmann
R, Vollmar B, and Burkhardt H (2006). Modulation of
granulocyte-endothelial interactions by antileukoproteinase: inhibition
of anti-type II collagen antibody-induced leukocyte-attachment to the
synovial endothelium. Arthritis Res Ther 8:R95. PubMed
Nandakumar KS* and Holmdahl R (2006).
Arthritis induced with cartilage-specific antibodies is IL-4 dependent. Eur J Immunol 36:1608-1618.
(Cover figure). * - corresponding author. PubMed
Dzhambazov
B, Nandakumar KS, Kihlberg J, Fugger L, Holmdahl R and
Vestberg M. (2006). Therapeutic vaccination of active arthritis with a
glycosylated collagen type II peptide in complex with MHC class II
molecules. J Immunol 176:1525-33. PubMed
Kumar A, Bansal V,
Nandakumar KS, Galaev IY, Roychoudhury
PK, Holmdahl R, Mattiasson B (2006).
Bioprocess integration for the production and isolation of urokinase
from animal cell culture using supermacroporous cryogel matrices
Biotechnol Bioeng 93:636-46. PubMed
Treschow A, Teige I, Nandakumar KS, Holmdahl R and Issazadeh-Navikas S (2005).
Stromal cells and osteoclasts are responsible for an exacerbated
collagen-induced arthritis in IFN-b deficient mice. Arthritis and
Rheum 52: 3739-40. PubMed
Bajtner E, Nandakumar
KS, Engström Å and Holmdahl R (2005). B cell fine
specificity
response to triple helical type II collagen along the disease course of
chronic relapsing collagen induced arthritis. Arthritis Res Ther
7:R1148-R1157. PubMed
Nandakumar KS* and Holmdahl R (2005).
Efficient induction of collagen antibody induced arthritis (CAIA) using
four antibodies specific for the major epitopes recognized in both
collagen-induced arthritis and rheumatoid arthritis. J Immunol methods
304:126-136. * - corresponding author.PubMed
Crombie DE,
Turer
M, Biurrun B, Wood B, McNaughton D, Nandakumar
KS, Holmdahl R, Van Damme M, Rowley MJ (2005).
Destructive effects of murine arthritogenic antibodies to
type II collagen on cartilage explants in vitro. Arthritis Res Ther
7:R927-R937. PubMed
Amirahmadi SF,
Whittingham S,
Crombie D, Nandakumar KS, Holmdahl R, Mackay IR, Van
Damme MP, Rowley MJ (2005). Arthritogenic anti-type II collagen
antibodies are pathogenic for cartilage-derived chondrocytes
independent of inflammatory cells. Arthritis and Rheum 52:1897-1906. PubMed
Nandakumar KS* and Holmdahl R (2005). A
genetic contamination in MHC congenic mouse strains reveals a locus on
chromosome 10 which determine autoimmunity and arthritis
susceptibility. Eur J Immunol 35:1275-82. * - corresponding author.PubMed
Johannesson M, Karlsson
J,
Wernhoff P, Nandakumar KS, Lindqvist A-K, Olsson L,
Cook A, Andersson A, Holmdahl R (2005). Dissection of a mouse QTL
associated with arthritis; formulation of the phenotype and the genetic
interactions through a partial advanced intercross strategy. Genes and
immunity 6:175-185. PubMed
Li J, Ny
A,
Leonardsson G, Nandakumar KS, Holmdahl
R and Ny T (2005). The plasminogen activator/plasmin system
is essential for development of the joint inflammatory phase of
collagen type II-induced arthritis. Am J pathol 166:783-92. PubMed
Kumar A,
Rodr’guez-Caballero A, Plieva FM, Galaev IY,
Nandakumar KS, Kamihira M, Holmdahl R,
Orfao A, Mattiasson B (2005).
Affinity Binding of Cells to Cryogel Adsorbents with Immobilized
Specific Ligands: Effect of Ligand Coupling and Matrix Architecture. J
Molecular Recognition 18:84-93. PubMed
Lange F,
Bajtner
E, Rintisch C, Nandakumar KS, Sack U, Holmdahl R
(2005). Methotrexate ameliorates T cell dependent autoimmune arthritis
and encephalomyelitis but not antibody or fibroblast induced arthritis.
Ann Rheum Dis
64:599-605. PubMed
Nandakumar
KS*,
Backlund J,
Vestberg M and Holmdahl R (2004). Collagen type II specific antibodies
induce arthritis in the absence of T or B cells but the arthritis
progression is enhanced by CII reactive T cells. Arthritis Res Ther
6:R544-50. * - corresponding author.PubMed
Xu Y, Ramsland PA, Davies
JM,
Scealy M, Nandakumar KS, Holmdahl R, Rowley MJ
(2004).Two monoclonal antibodies to precisely the same epitope of type
II collagen select non-crossreactive phage clones by phage display:
implications for autoimmunity and molecular mimicry. Molecular Immunol
41:411-419. PubMed
Sehnert B, Cavcic A,
Böhm
B, Kalden
JR,Nandakumar
KS, Holmdahl
R, Burkhardt H
(2004). Antileukoproteinase: Modulation of neutrophil function and
therapeutic effects on anti-collagen type II-antibody-induced
arthritis. Arthritis Rheum 50:2347-59. PubMed
Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl
R and Pekna M (2004). Complement activation by both
alternative and classical pathways is critical for the effector phase
of arthritis. Eur J Immunol 34:1208-16. PubMed
Hansson AS, Johannesson
M,
Svensson L, Nandakumar KS, Heineg Œrd H and Holmdahl R
(2004). Relapsing Polychondritis, induced in Mice with Matrilin 1, is
an Antibody- and Complement-Dependent Disease. Am J Pathol 164: 959-66.
PubMed
Nandakumar KS*, Svensson L, Holmdahl R
(2003). Collagen type II specific monoclonal antibody induced arthritis
(CAIA) in mice. Description of the disease and the influence of age,
sex, and genes. Am J pathol 163:1827-37. * -
corresponding author.PubMed
Backlund J, Nandakumar
KS, Bockermann R, Mori L Holmdahl R (2003). Genetic control of
tolerance to type II collagen and development of arthritis in an
autologous collagen-induced arthritis model. J Immunol 171:3493-9. PubMed
Nandakumar KS , Andren M ,
Martinsson P, Bajtner E, Hellstrom S, Holmdahl R, Kleinau
S (2003). Induction of arthritis by single monoclonal IgG
anti-collagen type II antibodies and enhancement of arthritis in mice
lacking inhibitory FcgRIIB. Eur J Immunol 33:2269-77. Co-first
authors. PubMed
Burkhardt H, Koller T,
Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG,
Kalden JR, Holmdahl R (2002). Antibody epitope specific
recognition of collagen type II in rheumatoid arthritis is shared with
arthritogenic antibodies in collagen induced arthritis. Arthritis Rheum
46:2339-48. PubMed
Svensson L, Nandakumar
KS, Johansson AC, Jansson L, Holmdahl R (2002). IL-4 deficient mice
develop less acute but more chronic relapsing arthritis. Eur J Immunol
32:2944-53. PubMed
Lindqvist AK, Bockermann
R,
Johansson AC, Nandakumar KS, Johannesson M, Holmdahl R
(2002). Mouse models for rheumatoid arthritis. Trends in Genetics
18(6): S7-13. Review.
Johansson AC, Hansson AS,
Nandakumar KS, Backlund J, Holmdahl R (2001). IL-10
deficient B10.Q mice develop more severe collagen induced arthritis but
are protected from arthritis induced with anti-type II collagen
antibodies. J Immunol 167: 3505–12. PubMed
Corthay A, Nandakumar
KS, Holmdahl R (2001). Evaluation of the percentage of peripheral T
cells with two different T cell receptor a chains and of their potential
roles in autoimmunity. J Autoimmun 16:423-9. PubMed
Nandakumar KS*, Muthukkaruppan VR (1999).
Influence of immunopotentiators on the anti-porin IgG subclass
distribution and protective immunity against murine salmonellosis. Scand J Immunol 50:188-94. * - corresponding author.PubMed
Nandakumar KS, Lakshmi Rao K, Pardhasaradhi
BV, Khar A (1999). Upregulation of anti-tumor immunity by IL-12 gene
transfected AK-5 tumor cells in vivo. Cytokines Cell Mol Ther 5:7-14. PubMed
Nandakumar KS, Varalakshmi C, Khar A
(1998). Role of cytokines in the maintenance of the memory immune
response induced by a rat histiocytoma in syngeneic hosts. Cytokines
Cell Mol Ther 4:169-75. PubMed
Nandakumar KS, Kumari AL, Khar A (1997).
Early expression of IL-12 p40 and IFN-g inhibits AK-5 tumor
regression. Cytokines Cell Mol Ther 3:225-32. PubMed
Nandakumar
KS,
Palanivel V,
Muthukkaruppan VR (1993). Diagnosis of Typhoid Fever: Detection of S.
typhi porins specific antibodies by Inhibition ELISA. Clin Exp Immunol
94:317-21. PubMed
Muthukkaruppan
VR, Nandakumar KS, Palanivel V (1992). Monoclonal
antibodies against Salmonella porins: Generation and Characterization.
Immunol Lett 33: 201-6. PubMed